Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…